Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
A Phase 2b clinical trial (Heffernan 2007, 300 obese patients) tested 1 mg/day subcutaneously over 12 weeks with a weight loss result of ~2.8 kg vs placebo
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
AOD-9604, also designated HGH fragment 176-191, is a modified 16-amino-acid peptide derived from the C-terminal region of human growth hormone
Oral solid-form research compound formulated for controlled analytical and investigational applications
View Profile
US$ 26.36
US$ 21.44
-1775582746855.png&w=3840&q=75)
US$ 26.40
US$ 24.13
